Broadwood Capital Inc., 10% Owner, Director at Lineage Cell Therapeutics, Inc. (LCTX), bought 15,789,474 shares at $0.76 ($12.0M) on 2025-01-27, disclosed to the SEC on 2025-01-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.76 | 7,894,737 | $6.0M | 50.0% |
| 2 | $0.76 | 7,894,737 | $6.0M | 50.0% |
| Total | $0.76 avg | 15,789,474 | $12.0M | 100% |
| Filing → |
| STAA | BUY | 2025-03-20 | $7.2M | — | Filing → |
| STAA | BUY | 2025-03-06 | $964K | — | Filing → |
| STAA | BUY | 2025-03-03 | $22.5M | — | Filing → |